|
|
 |
|
Viewing report
|
|
|
|
AstraZeneca PLC: SWOT Analysis & Company Profile
Business Review, July 2010, Pages: 24
Synopsis
Business Review’s AstraZeneca PLC contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning AstraZeneca PLC’s business.
Business Review’s “AstraZeneca PLC SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (AstraZeneca PLC) for business intelligence requirements
- Studies and presents AstraZeneca PLC’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company, engaged in the discovery, development, production and marketing of a broad range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Its research and development activities are focused on the development of implants and medical devices with principle focus on type 2 diabetes, infection, COPD, cancer, Alzheimer's diseases and other areas. The company has presence in more than 100 countries throughout the world. It has 17 research and development sites in eight countries as well as 20 manufacturing plants in 16 countries. AstraZeneca is headquartered in London, the UK.
|
|
|
|
